57. Idiopathic dilated cardiomyopathy Disease details / Clinical trials / Drug dev / DR info

150] MG PER DAY
   I.M. Sechenov First Moscow State Medical University
      2020   Phase 3   NCT05237323   Russia
5% dextrose
   University of California, Los Angeles
      2003   -   NCT00709163   United States
Abmc
   Queen Mary Innovation Centre, Queen Mary University of London
      2018   Phase 2   EUCTR2018-001063-23-GB   United Kingdom
Accucinch ventricular restoration system
   Ancora Heart, Inc.
      2020   -   NCT04331769   Belarus;Belgium;Czechia;France;Germany;Greece;Italy;Netherlands;Serbia;United States
ACE inhibitors
   Royal Brompton & Harefield NHS Foundation Trust
      2016   Phase 4   EUCTR2015-005351-27-GB   United Kingdom
Adenosine
   Duke University
      2017   Phase 4   NCT03249272   United States
AFTX-201
   Affinia Therapeutics
      2026   Phase 1/Phase 2   NCT07426419   United States
Aldactone*10conf 100MG
   AZIENDA OSPEDALIERA SENESE
      2006   -   EUCTR2006-001889-16-IT   Italy
Aldosterone antagonists
   Royal Brompton & Harefield NHS Foundation Trust
      2016   Phase 4   EUCTR2015-005351-27-GB   United Kingdom
Algisyl
   LoneStar Heart, Inc.
      2017   -   NCT03082508   -
Algisyl-LVR
   LoneStar Heart, Inc.
      2012   Phase 2/Phase 3   NCT01311791   Australia;Germany;Italy;Netherlands;New Zealand;Romania
Allogeneic cardiosphere-derived cells
   Capricor Inc.
      2014   Phase 1   NCT02293603   United States
Allogeneic hmscs
   Joshua M Hare
      2011   Phase 1/Phase 2   NCT01392625   United States
Allopurinol
   University of Pennsylvania
      2003   Phase 1/Phase 2   NCT00281255   United States
Allopurinol tablet
   Assiut University
      2022   -   NCT05193838   -
ALXN2350
   Alexion Pharmaceuticals, Inc.
      2025   Phase 1/Phase 2   NCT07218887   Italy;Spain;United Kingdom;United States
Anakinra
   OSPEDALE SAN RAFFAELE
      2022   Phase 2   EUCTR2020-005507-39-IT   Italy
Angiotensin LL antagonists, plain
   Royal Brompton & Harefield NHS Foundation Trust
      2016   Phase 4   EUCTR2015-005351-27-GB   United Kingdom
Aprovel*28CPR 150MG
   AZIENDA OSPEDALIERA SENESE
      2006   -   EUCTR2006-001889-16-IT   Italy
ARRY-371797
   ARRAY BIOPHARMA INC.
      2018   Phase 3   EUCTR2017-004310-25-IT   Argentina;Belgium;Canada;Denmark;France;Germany;Italy;Mexico;Netherlands;Norway;Spain;United Kingdom
   Array BioPharma Inc.
      2020   Phase 3   EUCTR2017-004310-25-NO   Argentina;Belgium;Canada;Denmark;France;Germany;Italy;Mexico;Netherlands;Norway;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004310-25-GB   Argentina;Belgium;Canada;France;Germany;Italy;Mexico;Netherlands;Norway;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004310-25-ES   Argentina;Belgium;Canada;Denmark;France;Germany;Italy;Mexico;Netherlands;Norway;Spain;United Kingdom;United States
   Array BioPharma Inc. (a wholly owned subsidiary of Pfizer Inc.)
      2022   Phase 3   EUCTR2017-004310-25-DK   Argentina;Austria;Belgium;Canada;Czechia;Denmark;Finland;France;Germany;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004310-25-NL   Argentina;Belgium;Canada;France;Germany;Italy;Mexico;Netherlands;Norway;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004310-25-BE   Argentina;Belgium;Canada;France;Germany;Italy;Mexico;Netherlands;Norway;Spain;United Kingdom;United States
   Pfizer
      2018   Phase 3   NCT03439514   Argentina;Belgium;Canada;Italy;Mexico;Netherlands;Norway;Spain;United Kingdom;United States
ARRY-371797, P38 inhibitor
   Pfizer
      2014   Phase 2   NCT02057341   United States
ARRY-371797, P38 inhibitor, oral
   Pfizer
      2015   Phase 2   NCT02351856   United States
Autologous bone marrow derived mononuclear cells
   Queen Mary Innovation Centre, Queen Mary University of London
      2018   Phase 2   EUCTR2018-001063-23-GB   United Kingdom
Autologous bone marrow-derived cells
   Johann Wolfgang Goethe University Hospital
      2001   -   NCT00962364   Germany
Autologous hmscs
   Joshua M Hare
      2011   Phase 1/Phase 2   NCT01392625   United States
Autologous stem cell therapy
   University Medical Centre Ljubljana
      2005   -   NCT02445534   Slovenia
Azathioprine OF 150 [75
   I.M. Sechenov First Moscow State Medical University
      2020   Phase 3   NCT05237323   Russia
AZD0233
   AstraZeneca
      2024   Phase 1   NCT06381466   United States
AZD4063
   AstraZeneca
      2025   Phase 1   NCT07241104   Netherlands
Benazepril
   Xijing Hospital
      2005   Phase 4   NCT01917149   China
Benidipine
   Tohoku University Graduate School of Medicine
      2015   -   JPRN-UMIN000021961   Japan
Bisoprolol
   AZIENDA OSPEDALIERA SENESE
      2006   -   EUCTR2006-001889-16-IT   Italy
Blood draw
   Universitätsmedizin Mannheim
      2019   -   NCT04146701   Germany
Blood sample collection
   Imperial College London
      2023   -   NCT05750147   United Kingdom
Blood test
   McGill University Health Center
      2008   -   NCT00523653   Canada
Bmmnc
   AININCAR
      2008   -   EUCTR2007-003088-36-ES   Spain
Bone marrow derived mononuclear cells and G-CSF
   Barts & The London NHS Trust
      2018   Phase 2   NCT03572660   United Kingdom
Bone marrow mononuclear cells
   AININCAR
      2008   -   EUCTR2007-003088-36-ES   Spain
   Barts & The London NHS Trust
      2010   Phase 2   NCT01302171   United Kingdom
Bone marrow stimulation
   University Medical Centre Ljubljana
      2006   Phase 2   NCT00629018   Slovenia
Brain magnetic resonance
   Hospital General Universitario Gregorio Marañon
      2020   -   NCT04649034   Spain
      2018   -   NCT03415789   Spain
Bromocriptine mesylate plus standard gdmt
   Jimma University
      2024   Phase 3   NCT06250257   Ethiopia
Bumetanide
   Royal Brompton & Harefield NHS Foundation Trust
      2016   Phase 4   EUCTR2015-005351-27-GB   United Kingdom
C03C
   Royal Brompton & Harefield NHS Foundation Trust
      2016   Phase 4   EUCTR2015-005351-27-GB   United Kingdom
Candesartan
   Cristina Avendaño Solá
      2022   Phase 3   NCT05321875   Spain
   FUNDACION INVESTIGACION BIOMEDICA HOSPITAL PUERTA DE HIERRO MAJADAHONDA
      2022   Phase 3   EUCTR2021-004577-30-ES   Spain
   Royal Brompton & Harefield NHS Foundation Trust
      2016   Phase 4   EUCTR2015-005351-27-GB   United Kingdom
CandesartáN kern pharma 16 MG comprimidos EFG
   FUNDACION INVESTIGACION BIOMEDICA HOSPITAL PUERTA DE HIERRO MAJADAHONDA
      2022   Phase 3   EUCTR2021-004577-30-ES   Spain
Captopril
   Royal Brompton & Harefield NHS Foundation Trust
      2016   Phase 4   EUCTR2015-005351-27-GB   United Kingdom
Cardap-zellen
   Charité - Universitätsmedizin Berlin
      2019   Phase 1;Phase 2   EUCTR2014-003457-34-DE   Germany
Cardapcells
   Charité - Universitätsmedizin Berlin
      2019   Phase 1;Phase 2   EUCTR2014-003457-34-DE   Germany
Cardiac magnetic resonance
   Children's Hospital of Chongqing Medical University
      2026   -   ChiCTR2600124263   China
   Hospital General Universitario Gregorio Marañon
      2020   -   NCT04649034   Spain
      2018   -   NCT03415789   Spain
Carvedilol
   Department Of Paediatric Cardiology
      -   Phase 4   EUCTR2006-003075-12-IE   Ireland
   Medical University of Silesia
      2006   Phase 4   NCT00374465   Poland
   October 6 University
      2023   Phase 3   NCT05849766   Egypt
   University of Colorado, Denver
      2000   Phase 4   NCT01798992   United States
CD34+ autologous stem cell transplantation
   University Medical Centre Ljubljana
      2006   Phase 2   NCT00629018   Slovenia
CDC infusion
   Okayama University
      2017   Phase 1   NCT03129568   Japan
Cell
   Ministry of Health, Brazil
      2006   Phase 3   NCT00333827   Brazil
   Yamashita Jun
      2024   Phase 1-2   JPRN-jRCT2033240447   -
Clenbuterol
   AZIENDA OSPEDALIERA SENESE
      2006   -   EUCTR2006-001889-16-IT   Italy
   Francis D. Pagani
      2007   Phase 1   NCT00585546   United States
Close follow-UP
   RenJi Hospital
      2025   -   NCT06794710   China
Coagulation blood test
   Hospital General Universitario Gregorio Marañon
      2020   -   NCT04649034   Spain
      2018   -   NCT03415789   Spain
Coenzyme Q10
   University of Tehran
      2006   Phase 4   NCT02115581   Iran, Islamic Republic of
Concor mite*28CPR 5MG
   AZIENDA OSPEDALIERA SENESE
      2006   -   EUCTR2006-001889-16-IT   Italy
Controls
   Universidad Los Andes, Chile
      2012   Phase 1/Phase 2   NCT01739777   Chile
COR-1
   Corimmun GmbH
      2011   -   EUCTR2010-022579-68-DE   Germany
Corlanor
   IRCCS, OSPEDALE PEDIATRICO BAMBINO GESÙ DI ROMA
      2020   Phase 2   EUCTR2019-003902-29-IT   Italy
Coversyl 5MG
   Inserm
      2012   -   EUCTR2010-023184-18-DK   Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2011   -   EUCTR2010-023184-18-ES   Denmark;Spain
Células mononucleares troncales adultas AUTólogas DE Médula óSEA NO expandidas
   Fundación Progreso y Salud
      2013   Phase 3   EUCTR2013-002015-98-ES   Spain
Danicamtiv
   Bristol-Myers Squibb
      2020   Phase 2   NCT04572893   Germany;Spain;United Kingdom;United States
   Kardigan, Inc.
      2026   Phase 2/Phase 3   NCT07210723   Denmark;France;Hungary;Italy;Poland;Spain;Sweden;United Kingdom;United States
   MyoKardia Inc.
      2020   Phase 2   EUCTR2019-003626-24-DE   Germany;Spain;United Kingdom;United States
Dapagliflozin
   October 6 University
      2023   Phase 3   NCT05849766   Egypt
Dietary nitrate
   Royal College of Surgeons, Ireland
      2015   -   NCT02471417   -
Digoxin+furosemide+captopril
   Damascus University
      2021   -   NCT04893629   Syrian Arab Republic
Diuretics, aceis/arbs, beta blockers, positive inotropic drugs, mras, SGLT2I, retinoids
   RenJi Hospital
      2025   -   NCT06794710   China
Dobutamine
   University of Pennsylvania
      2003   Phase 1/Phase 2   NCT00281255   United States
Doppler echocardiogram exam
   Hospital General Universitario Gregorio Marañon
      2020   -   NCT04649034   Spain
      2018   -   NCT03415789   Spain
Early rehabilitation guidance
   RenJi Hospital
      2025   -   NCT06794710   China
Empagliflozin tablets
   Sebastiano Lava
      2025   Phase 2   NCT06643442   United Kingdom
Enalapril
   Royal Brompton & Harefield NHS Foundation Trust
      2016   Phase 4   EUCTR2015-005351-27-GB   United Kingdom
Enalapril maleate
   Ethicare GmbH
      2017   Phase 3   EUCTR2015-002397-21-DE   Austria;Germany;Hungary;Netherlands;Serbia;United Kingdom
      2017   Phase 3   EUCTR2015-002335-17-DE   Austria;Germany;Hungary;Netherlands;Serbia;United Kingdom
      2015   -   EUCTR2015-002397-21-NL   Austria;Hungary;Netherlands;Serbia;United Kingdom
      2015   Phase 3   EUCTR2015-002397-21-HU   Austria;Germany;Hungary;Netherlands;Serbia;United Kingdom
      2015   -   EUCTR2015-002397-21-GB   Austria;Hungary;Netherlands;Serbia;United Kingdom
      2015   Phase 3   EUCTR2015-002397-21-AT   Austria;Germany;Hungary;Netherlands;Serbia;United Kingdom
      2015   Phase 3   EUCTR2015-002335-17-NL   Austria;Germany;Hungary;Netherlands;Serbia;United Kingdom
      2015   Phase 3   EUCTR2015-002335-17-HU   Austria;Germany;Hungary;Netherlands;Serbia;United Kingdom
      2015   -   EUCTR2015-002335-17-GB   Austria;Hungary;Netherlands;Serbia;United Kingdom
      2015   Phase 3   EUCTR2015-002335-17-AT   Austria;Germany;Hungary;Netherlands;Serbia;United Kingdom
Enalapril orodispersible minitablet
   Ethicare GmbH
      2017   Phase 3   EUCTR2015-002397-21-DE   Austria;Germany;Hungary;Netherlands;Serbia;United Kingdom
      2016   Phase 2/Phase 3   NCT02654678   Austria;Hungary;Netherlands;Serbia;United Kingdom
      2016   Phase 2/Phase 3   NCT02652728   Austria;Hungary;Netherlands;Serbia;United Kingdom
      2015   -   EUCTR2015-002397-21-NL   Austria;Hungary;Netherlands;Serbia;United Kingdom
      2015   Phase 3   EUCTR2015-002397-21-HU   Austria;Germany;Hungary;Netherlands;Serbia;United Kingdom
      2015   -   EUCTR2015-002397-21-GB   Austria;Hungary;Netherlands;Serbia;United Kingdom
      2015   Phase 3   EUCTR2015-002397-21-AT   Austria;Germany;Hungary;Netherlands;Serbia;United Kingdom
      2015   Phase 3   EUCTR2015-002335-17-NL   Austria;Germany;Hungary;Netherlands;Serbia;United Kingdom
      2015   Phase 3   EUCTR2015-002335-17-HU   Austria;Germany;Hungary;Netherlands;Serbia;United Kingdom
      2015   -   EUCTR2015-002335-17-GB   Austria;Hungary;Netherlands;Serbia;United Kingdom
      2015   Phase 3   EUCTR2015-002335-17-AT   Austria;Germany;Hungary;Netherlands;Serbia;United Kingdom
Enalapril orodispersible minitablets
   Ethicare GmbH
      2017   Phase 3   EUCTR2015-002397-21-DE   Austria;Germany;Hungary;Netherlands;Serbia;United Kingdom
      2017   Phase 3   EUCTR2015-002335-17-DE   Austria;Germany;Hungary;Netherlands;Serbia;United Kingdom
      2015   -   EUCTR2015-002397-21-NL   Austria;Hungary;Netherlands;Serbia;United Kingdom
      2015   Phase 3   EUCTR2015-002397-21-HU   Austria;Germany;Hungary;Netherlands;Serbia;United Kingdom
      2015   -   EUCTR2015-002397-21-GB   Austria;Hungary;Netherlands;Serbia;United Kingdom
      2015   Phase 3   EUCTR2015-002397-21-AT   Austria;Germany;Hungary;Netherlands;Serbia;United Kingdom
      2015   Phase 3   EUCTR2015-002335-17-NL   Austria;Germany;Hungary;Netherlands;Serbia;United Kingdom
      2015   Phase 3   EUCTR2015-002335-17-HU   Austria;Germany;Hungary;Netherlands;Serbia;United Kingdom
      2015   -   EUCTR2015-002335-17-GB   Austria;Hungary;Netherlands;Serbia;United Kingdom
      2015   Phase 3   EUCTR2015-002335-17-AT   Austria;Germany;Hungary;Netherlands;Serbia;United Kingdom
Eplerenone
   Royal Brompton & Harefield NHS Foundation Trust
      2016   Phase 4   EUCTR2015-005351-27-GB   United Kingdom
Eucardic
   Department Of Paediatric Cardiology
      -   Phase 4   EUCTR2006-003075-12-IE   Ireland
FAP immunosuppressive CAR-DC
   Second Affiliated Hospital, School of Medicine, Zhejiang University
      2026   Phase 1   NCT07516288   -
      2025   Phase 1   NCT06902896   China
Flutamide
   Onoue Kenji
      2013   -   JPRN-jRCTs051180123   -
Furosemide
   Royal Brompton & Harefield NHS Foundation Trust
      2016   Phase 4   EUCTR2015-005351-27-GB   United Kingdom
Guideline-directed medical therapy
   Ancora Heart, Inc.
      2020   -   NCT04331769   Belarus;Belgium;Czechia;France;Germany;Greece;Italy;Netherlands;Serbia;United States
HIGH-ceiling diuretics
   Royal Brompton & Harefield NHS Foundation Trust
      2016   Phase 4   EUCTR2015-005351-27-GB   United Kingdom
Hipsc-CM therapy
   Help Therapeutics
      2021   Phase 1   NCT04982081   China
Holter monitoring
   Hospital General Universitario Gregorio Marañon
      2020   -   NCT04649034   Spain
Honey
   mamdouh abdulmaksoud abdulrhman
      2015   Phase 2/Phase 3   NCT02987322   -
Htea
   Harbin Medical University
      2013   -   NCT02292043   China
Hyperpolarized 13C-pyruvate
   University of Texas Southwestern Medical Center
      2018   -   NCT03057002   United States
Infusion OF autologous mononuclear bone marrow cells
   Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud
      2014   Phase 2   NCT02033278   Spain
Intracoronary administration OF umbilical CORD-derived mscs
   The Research-Clinical Center for Cardiac Surgery and Transplantology LLP
      2020   Phase 1/Phase 2   NCT04325594   Kazakhstan
Irbesartan
   AZIENDA OSPEDALIERA SENESE
      2006   -   EUCTR2006-001889-16-IT   Italy
   Royal Brompton & Harefield NHS Foundation Trust
      2016   Phase 4   EUCTR2015-005351-27-GB   United Kingdom
Ivabradine
   INSTITUT DE RECHERCHES INTERNATIONALES SERVIER
      2011   -   EUCTR2011-001292-39-IT   Australia;Brazil;Canada;Denmark;Finland;Germany;Hungary;India;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
   Institut de Recherches Internationales Servier
      2012   -   EUCTR2011-001292-39-PT   Australia;Belgium;Brazil;Canada;Denmark;Finland;Germany;Hungary;India;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      2012   -   EUCTR2011-001292-39-DK   Australia;Belgium;Brazil;Croatia;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;South Africa;Spain;Sweden;United Kingdom
      2012   -   EUCTR2011-001292-39-DE   Australia;Belgium;Brazil;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      2011   -   EUCTR2011-001292-39-SE   Australia;Brazil;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      2011   -   EUCTR2011-001292-39-HU   Australia;Brazil;Canada;Denmark;Finland;Germany;Hungary;India;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      2011   Phase 2   EUCTR2011-001292-39-GB   Australia;Belgium;Brazil;Bulgaria;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      2011   -   EUCTR2011-001292-39-FI   Australia;Brazil;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      2011   Phase 2   EUCTR2011-001292-39-BE   Australia;Belgium;Brazil;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      -   Phase 2   EUCTR2011-001292-39-BG   Australia;Belgium;Brazil;Bulgaria;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
   Lab Servier
      2011   Phase 2   EUCTR2011-001292-39-ES   Australia;Belgium;Brazil;Bulgaria;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
Ivabradine 5MG TAB
   Bambino Gesù Hospital and Research Institute
      2020   Phase 2   NCT04405804   Italy
Ixmyelocel-T
   Vericel Corporation
      2013   Phase 2   NCT01670981   Canada;United States
      2009   Phase 2   NCT01020968   United States
      2008   Phase 2   NCT00765518   United States
JV001
   Shanghai East Hospital
      2023   Early Phase 1   NCT05837143   China
Kineret - 100 MG/0,67 ML soluzione iniettabile USO sottocutaneo siringa preriempita 7 siringhe preriempite
   OSPEDALE SAN RAFFAELE
      2022   Phase 2   EUCTR2020-005507-39-IT   Italy
Lenograstim
   Barts & the London NHS Trust
      2010   -   EUCTR2009-013112-12-GB   United Kingdom
Levosimendan
   Fuwai Hospital, Chinese Academy of Medical Sciences
      2021   Phase 4   ChiCTR2100046778   China
Lisinopril
   Royal Brompton & Harefield NHS Foundation Trust
      2016   Phase 4   EUCTR2015-005351-27-GB   United Kingdom
Losartan
   Royal Brompton & Harefield NHS Foundation Trust
      2016   Phase 4   EUCTR2015-005351-27-GB   United Kingdom
Mangafodipir trisodium
   University of Edinburgh
      2018   -   NCT03607669   United Kingdom
Metoprolol
   Xijing Hospital
      2005   Phase 4   NCT01917149   China
Metoprolol succinate + doxazosin
   University of Colorado, Denver
      2000   Phase 4   NCT01798992   United States
Mitoq compound
   Imperial College London
      2022   Phase 2   NCT05410873   United Kingdom
Mono nuclear cell (MNC) transplantation
   Nasser Aghdami MD., PhD
      2013   Phase 1/Phase 2   NCT02256501   Iran, Islamic Republic of
Mono nuclear cells injection
   Damascus University
      2021   -   NCT04893629   Syrian Arab Republic
Mycophenolate mofetil
   Yamashita Jun
      2024   Phase 1-2   JPRN-jRCT2033240447   -
Mycophenolate mofetil 2 G PER DAY
   I.M. Sechenov First Moscow State Medical University
      2020   Phase 3   NCT05237323   Russia
MYK-491
   MyoKardia Inc.
      2020   Phase 2   EUCTR2019-003626-24-GB   Germany;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-003626-24-DE   Germany;Spain;United Kingdom;United States
   MyoKardia, Inc.
      2018   Phase 1/Phase 2   NCT03447990   France;Germany;Netherlands;Poland;Sweden;United Kingdom;United States
      2017   Phase 1   NCT03062956   Australia
N-3 pufas
   Università degli Studi di Brescia
      2007   Phase 3   NCT01223703   Italy
Nanogam
   Sanquin Plasma Products
      2009   Phase 3   EUCTR2009-009463-61-NL   Netherlands
Nesiritide
   University of California, Los Angeles
      2003   -   NCT00709163   United States
NVC-001 - high dose
   Nuevocor Pte. Ltd.
      2026   Phase 1/Phase 2   NCT07606274   United States
NVC-001 - intermediate dose
   Nuevocor Pte. Ltd.
      2026   Phase 1/Phase 2   NCT07606274   United States
NVC-001 - LOW dose
   Nuevocor Pte. Ltd.
      2026   Phase 1/Phase 2   NCT07606274   United States
Olmesartan medoxomil
   Royal Brompton & Harefield NHS Foundation Trust
      2016   Phase 4   EUCTR2015-005351-27-GB   United Kingdom
Optimal therapy FOR cardiaca failure
   Ministry of Health, Brazil
      2006   Phase 3   NCT00333827   Brazil
Oral glucose tolerance test
   Le Bonheur Children's Hospital
      2019   -   NCT04222101   United States
Peridopril arginine
   Inserm
      2012   -   EUCTR2010-023184-18-DK   Denmark;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
Perindopril
   Institut National de la Santé Et de la Recherche Médicale, France
      2011   Phase 3   NCT01583114   Denmark;France;Germany;Italy;Netherlands;Spain;United Kingdom
Perindopril arginine
   Inserm
      2011   -   EUCTR2010-023184-18-ES   Denmark;Spain
PF-07265803
   Array BioPharma Inc.
      2018   Phase 3   EUCTR2017-004310-25-GB   Argentina;Belgium;Canada;France;Germany;Italy;Mexico;Netherlands;Norway;Spain;United Kingdom;United States
   Array BioPharma Inc. (a wholly owned subsidiary of Pfizer Inc.)
      2022   Phase 3   EUCTR2017-004310-25-DK   Argentina;Austria;Belgium;Canada;Czechia;Denmark;Finland;France;Germany;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Norway;Poland;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2017-004310-25-NL   Argentina;Belgium;Canada;France;Germany;Italy;Mexico;Netherlands;Norway;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2017-004310-25-BE   Argentina;Belgium;Canada;France;Germany;Italy;Mexico;Netherlands;Norway;Spain;United Kingdom;United States
   Pfizer
      2018   Phase 3   NCT03439514   Argentina;Belgium;Canada;Italy;Mexico;Netherlands;Norway;Spain;United Kingdom;United States
Potassium sparing agents
   Royal Brompton & Harefield NHS Foundation Trust
      2016   Phase 4   EUCTR2015-005351-27-GB   United Kingdom
Prednisolone
   Yamashita Jun
      2024   Phase 1-2   JPRN-jRCT2033240447   -
Procoralan
   INSTITUT DE RECHERCHES INTERNATIONALES SERVIER
      2011   -   EUCTR2011-001292-39-IT   Australia;Brazil;Canada;Denmark;Finland;Germany;Hungary;India;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
   IRCCS, OSPEDALE PEDIATRICO BAMBINO GESÙ DI ROMA
      2020   Phase 2   EUCTR2019-003902-29-IT   Italy
   Institut de Recherches Internationales Servier
      2012   -   EUCTR2011-001292-39-PT   Australia;Belgium;Brazil;Canada;Denmark;Finland;Germany;Hungary;India;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      2012   -   EUCTR2011-001292-39-DK   Australia;Belgium;Brazil;Croatia;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;South Africa;Spain;Sweden;United Kingdom
      2012   -   EUCTR2011-001292-39-DE   Australia;Belgium;Brazil;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      2011   -   EUCTR2011-001292-39-SE   Australia;Brazil;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      2011   -   EUCTR2011-001292-39-HU   Australia;Brazil;Canada;Denmark;Finland;Germany;Hungary;India;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      2011   Phase 2   EUCTR2011-001292-39-GB   Australia;Belgium;Brazil;Bulgaria;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      2011   -   EUCTR2011-001292-39-FI   Australia;Brazil;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      2011   Phase 2   EUCTR2011-001292-39-BE   Australia;Belgium;Brazil;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      -   Phase 2   EUCTR2011-001292-39-BG   Australia;Belgium;Brazil;Bulgaria;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
   Lab Servier
      2011   Phase 2   EUCTR2011-001292-39-ES   Australia;Belgium;Brazil;Bulgaria;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
Qiliqiangxin capsule
   Harbin Medical University
      2012   -   NCT02283450   -
   Huazhong University of Science and Technology
      2012   Phase 4   NCT01293903   China
Ramipril
   October 6 University
      2023   Phase 3   NCT05849766   Egypt
Ranolazine
   University Medical Centre Ljubljana
      2014   Phase 2   NCT02133911   Slovenia
Rasi plus carvedilol
   Federal University of Minas Gerais
      2003   Phase 4   NCT01557140   Brazil
Regadenoson
   Duke University
      2017   Phase 4   NCT03249272   United States
Resveratrol
   St. Boniface Hospital
      2018   Phase 3   NCT01914081   Canada
Rosiglitazone therapy
   Stanford University
      2007   -   NCT00466713   United States
Rosuvastatin
   Oslo University Hospital
      2007   Phase 3   NCT00505154   Norway
S16257-2
   INSTITUT DE RECHERCHES INTERNATIONALES SERVIER
      2011   -   EUCTR2011-001292-39-IT   Australia;Brazil;Canada;Denmark;Finland;Germany;Hungary;India;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
   Institut de Recherches Internationales Servier
      2012   -   EUCTR2011-001292-39-PT   Australia;Belgium;Brazil;Canada;Denmark;Finland;Germany;Hungary;India;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      2012   -   EUCTR2011-001292-39-DK   Australia;Belgium;Brazil;Croatia;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;South Africa;Spain;Sweden;United Kingdom
      2012   -   EUCTR2011-001292-39-DE   Australia;Belgium;Brazil;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      2011   -   EUCTR2011-001292-39-SE   Australia;Brazil;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      2011   -   EUCTR2011-001292-39-HU   Australia;Brazil;Canada;Denmark;Finland;Germany;Hungary;India;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      2011   Phase 2   EUCTR2011-001292-39-GB   Australia;Belgium;Brazil;Bulgaria;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      2011   -   EUCTR2011-001292-39-FI   Australia;Brazil;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      2011   Phase 2   EUCTR2011-001292-39-BE   Australia;Belgium;Brazil;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      -   Phase 2   EUCTR2011-001292-39-BG   Australia;Belgium;Brazil;Bulgaria;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
   Lab Servier
      2011   Phase 2   EUCTR2011-001292-39-ES   Australia;Belgium;Brazil;Bulgaria;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
S16527-2
   Institut de Recherches Internationales Servier
      2012   -   EUCTR2011-001292-39-PT   Australia;Belgium;Brazil;Canada;Denmark;Finland;Germany;Hungary;India;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      2012   -   EUCTR2011-001292-39-DK   Australia;Belgium;Brazil;Croatia;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;South Africa;Spain;Sweden;United Kingdom
      2012   -   EUCTR2011-001292-39-DE   Australia;Belgium;Brazil;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      2011   -   EUCTR2011-001292-39-SE   Australia;Brazil;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      2011   -   EUCTR2011-001292-39-HU   Australia;Brazil;Canada;Denmark;Finland;Germany;Hungary;India;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      2011   Phase 2   EUCTR2011-001292-39-GB   Australia;Belgium;Brazil;Bulgaria;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      2011   -   EUCTR2011-001292-39-FI   Australia;Brazil;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      2011   Phase 2   EUCTR2011-001292-39-BE   Australia;Belgium;Brazil;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      -   Phase 2   EUCTR2011-001292-39-BG   Australia;Belgium;Brazil;Bulgaria;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
   Lab Servier
      2011   Phase 2   EUCTR2011-001292-39-ES   Australia;Belgium;Brazil;Bulgaria;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
SC therapy
   University Medical Centre Ljubljana
      2006   Phase 2   NCT00629018   Slovenia
Simvastatin therapy
   National Taiwan University Hospital
      2020   Phase 2   NCT06632834   Taiwan
Sirolimus
   Tongji Hospital
      2024   Phase 4   NCT06236022   China
Spironolactone
   AZIENDA OSPEDALIERA SENESE
      2006   -   EUCTR2006-001889-16-IT   Italy
   October 6 University
      2023   Phase 3   NCT05849766   Egypt
   Royal Brompton & Harefield NHS Foundation Trust
      2016   Phase 4   EUCTR2015-005351-27-GB   United Kingdom
   Vanderbilt University
      2007   Phase 4   NCT00574119   United States
Spiropent*30CPR 0,02MG
   AZIENDA OSPEDALIERA SENESE
      2006   -   EUCTR2006-001889-16-IT   Italy
SRD-001
   Sardocor Corp.
      2024   Phase 1   NCT06224660   United States
Standard medical therapy
   Fuwai Hospital, Chinese Academy of Medical Sciences
      2021   Phase 4   ChiCTR2100046778   China
   LoneStar Heart, Inc.
      2017   -   NCT03082508   -
      2012   Phase 2/Phase 3   NCT01311791   Australia;Germany;Italy;Netherlands;New Zealand;Romania
Standard OF care
   McGill University
      2016   -   NCT02770443   Canada
   Vericel Corporation
      2008   Phase 2   NCT00765518   United States
Stem cell injection
   Great Ormond Street Hospital for Children NHS Foundation Trust
      2008   -   NCT02479776   -
Stem cell therapy
   University Medical Centre Ljubljana
      2014   Phase 2/Phase 3   NCT02248532   Slovenia
SUB08357MIG
   Institut de Recherches Internationales Servier
      2012   -   EUCTR2011-001292-39-PT   Australia;Belgium;Brazil;Canada;Denmark;Finland;Germany;Hungary;India;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      2012   -   EUCTR2011-001292-39-DK   Australia;Belgium;Brazil;Croatia;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;South Africa;Spain;Sweden;United Kingdom
      2012   -   EUCTR2011-001292-39-DE   Australia;Belgium;Brazil;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      2011   -   EUCTR2011-001292-39-SE   Australia;Brazil;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      2011   -   EUCTR2011-001292-39-HU   Australia;Brazil;Canada;Denmark;Finland;Germany;Hungary;India;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      2011   Phase 2   EUCTR2011-001292-39-GB   Australia;Belgium;Brazil;Bulgaria;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      2011   -   EUCTR2011-001292-39-FI   Australia;Brazil;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      2011   Phase 2   EUCTR2011-001292-39-BE   Australia;Belgium;Brazil;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
      -   Phase 2   EUCTR2011-001292-39-BG   Australia;Belgium;Brazil;Bulgaria;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
   Lab Servier
      2011   Phase 2   EUCTR2011-001292-39-ES   Australia;Belgium;Brazil;Bulgaria;Denmark;Finland;Germany;Hungary;Italy;Mexico;Portugal;Russian Federation;Spain;Sweden;United Kingdom
Tacrolimus
   Yamashita Jun
      2024   Phase 1-2   JPRN-jRCT2033240447   -
Talfirastide
   Constant Therapeutics LLC
      2023   Phase 2   NCT06013839   Israel
Telmisartan
   Royal Brompton & Harefield NHS Foundation Trust
      2016   Phase 4   EUCTR2015-005351-27-GB   United Kingdom
Tulip
   Medical Universtity of Lodz
      2007   -   NCT01015144   -
Ucmsc
   Universidad Los Andes, Chile
      2012   Phase 1/Phase 2   NCT01739777   Chile
Umbilical cord mesenchymal stem cells
   Qingdao University
      2010   Phase 1/Phase 2   NCT01219452   China
Valsartan
   Royal Brompton & Harefield NHS Foundation Trust
      2016   Phase 4   EUCTR2015-005351-27-GB   United Kingdom
   Xijing Hospital
      2005   Phase 4   NCT01917149   China
Vehicle control
   Vericel Corporation
      2009   Phase 2   NCT01020968   United States
Verapamil
   Medical University of Silesia
      2006   Phase 4   NCT00374465   Poland
Water
   Barts & the London NHS Trust
      2010   -   EUCTR2009-013112-12-GB   United Kingdom
Water-soluble ubiquinol
   Chung Shan Medical University
      2016   -   NCT02847585   Taiwan
Withdrawal
   McGill University
      2016   -   NCT02770443   Canada